# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Moderna's stock drops after cutting 2024 sales forecast due to reduced COVID-19 vaccine demand. The company now expects net...
- Conference Call
For the second half of the year, it expects a sales split of 40-50% in the third quarter with the balance in the fourth quarter...
Directors Robert Langer and Stephen Berenson will also retire from the Board.